CMS Expands Coverage of Lung Cancer Screening with Low Dose Computed Tomography
(Source – www.cms.gov) Today the Centers for Medicare & Medicaid Services (CMS) is announcing a national coverage determination (NCD) that
Read More
CMS
CMS releases over-the-counter COVID-19 testing coverage guidance
(By Nick Moran for Becker’s Hospital Review) CMS released additional guidance Feb. 4 on how payers should best cover at-home
Read MoreHealth Care Paradox: Medicare Penalizes Dozens of Hospitals It Also Gives Five Stars
(By Jordan Rau for Kaiser Health News) The federal government has penalized 764 hospitals — including more than three dozen
Read MoreCMS pitches Medicare Advantage rate, Part D payment policy changes: 9 details
(By Nick Moran for Becker’s Hospital Review) CMS is seeking input on an Advanced Notice that includes proposed changes to
Read MoreAs internet access limits telehealth’s reach, insurers are starting to cover the bill
(By Katie Palmer for STAT) Billions of dollars have been poured into telehealth during the pandemic: Insurers loosened the purse
Read MoreOver-the-counter COVID tests will soon be free for Medicare recipients
(By Alana Wise for NPR) Medicare and Medicare Advantage recipients will be eligible for free over-the-counter COVID-19 tests beginning in
Read MoreLawmakers urge CMS to ensure Medicare Advantage can continue
Almost 80 percent of the U.S. House of Representatives are urging CMS to “provide a stable rate and policy environment
Read MoreTo Advance Information on Quality of Care, CMS Makes Nursing Home Staffing Data Available
(Source – CMS.gov) As part of its commitment to improve transparency and help families and caregivers find the best quality
Read More19 senators urge Medicare to cover at-home COVID-19 tests
(By Nick Moran for Becker’s Hospital Review) Nineteen senators co-signed a letter to HHS and CMS urging the agencies to
Read MorePatient groups, lobbyists pressure CMS to expand Aduhelm coverage
(By Nick Moran for Becker’s Hospital Review) Following CMS’s preliminary decision to limit the coverage of Biogen’s Alzehimer’s disease treatment
Read More